In the quest for novel dual A1/A2A AR antagonists as putative agents for the treatment of Parkinson’s disease, we applied a multistage virtual screening approach combining deep learning, pharmacophore and molecular docking methods to screen the ChemDiv library (1,178,506 compounds) and tested 19 hits by in vitro assays. Here, AR is linked to Parkinson disease.